Literature DB >> 3524338

Pituitary tumors secreting growth hormone and prolactin.

S Melmed, G D Braunstein, R J Chang, D P Becker.   

Abstract

The pathophysiology of functional adenomas of the anterior pituitary gland can be understood in the context of the central neural control of anterior pituitary secretion and by the fact that the cell types of the anterior pituitary gland generally express a single polypeptide hormone. Functional pituitary adenomas arise de novo from one or more of these cell types, but a defect in hypothalamic regulation can contribute to tumorigenesis and sometimes result in persistent tumor recurrence despite local surgical cure. The recent advances in molecular biology, radioimmunoassay, neuroradiology, and transsphenoidal microneurosurgery techniques have greatly improved our understanding of the pathophysiology of these tumors, enhanced diagnostic accuracy, and led to newer medical and surgical therapeutic approaches. This conference reviews the molecular and cellular pathophysiology, causes, diagnosis, clinical features, and medical and surgical management of the two common functional pituitary adenomas, prolactinoma and somatotropinoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524338     DOI: 10.7326/0003-4819-105-2-238

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Loss of vision due to a physiologic pituitary enlargement during normal pregnancy.

Authors:  Toshihiro Inoue; Akihiro Hotta; Maiko Awai; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12-20       Impact factor: 3.117

2.  Pituitary carcinoma.

Authors:  M D Cusimano; P Ohori; A J Martinez; C Jungreis; D C Wright
Journal:  Skull Base Surg       Date:  1994

Review 3.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

Review 4.  Managing prolactin-secreting adenomas during pregnancy.

Authors:  Syed Ali Imran; Ehud Ur; David B Clarke
Journal:  Can Fam Physician       Date:  2007-04       Impact factor: 3.275

5.  Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma).

Authors:  M Berezin; I Shimon; M Hadani
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

6.  Hyperostosis frontalis interna, acromegaly and hyperprolactinaemia.

Authors:  J D Fulton; J Shand; D Ritchie; J McGhee
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

Review 7.  Acromegaly update--etiology, diagnosis and management.

Authors:  S Melmed; J A Fagin
Journal:  West J Med       Date:  1987-03

8.  Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly.

Authors:  C de la Piedra; J Larrañaga; N Castro; C Horcajada; A Rapado; J L Herrera Pombo; E Carbó
Journal:  Calcif Tissue Int       Date:  1988-07       Impact factor: 4.333

Review 9.  Diagnosis and drug therapy of prolactinoma.

Authors:  E Ciccarelli; F Camanni
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

10.  Case report: Bilateral simple Syndactyly in a toddler with maternal exposure to cabergoline.

Authors:  Shima Afshar; Mohammad Abbasinazari; Behnam Darvishi; Shadi Ziaie; Hadi Esmaily
Journal:  Clin Case Rep       Date:  2022-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.